Program Description: 

This educational activity is designed to provide a learning environment that provides interactive discussions on up to date medical information, treatment plans, options and protocols, along with the risks, benefits and outcomes of treatment on adult musculoskeletal oncology patients. This is a discussed in a multidisciplinary format that creates a well rounded unbiased discussion amongst colleagues.  It creates an environment for dynamic discussion and debates on patient care and the treatment resources available. It provides the opportunity for consistent tailored individual treatment protocols per patient.

NCCN and other national guidelines are used in patient treatment planning unless otherwise stated by the physician

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0  AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.

Target audience: 

Physicians
Allied Health Care Professionals

Learning objectives: 
  • Apply recent updates to treatment plans and protocols based on the discussions of the patient’s treatment at tumor board
  • Expand our discussions to include the most recent and relevant literature evaluations on musculoskeletal oncology and disease protocols and treatment outcomes
  • Continue to collaborate as a multidisciplinary unit to treat the patient as a whole and utilize treatment resources efficiently
  • Publish research that is up to date and relevant to current literature
Faculty & credentials: 

Activity Director(s)Don Hackbarth, MD, David King, MD and Lori Hollingsworth-Burds, PA-C

In accordance with the ACCME policy on relevant financial disclosure, the following planners disclosed that they have the following commercial interests. These relationships were reviewed via the MCW conflict of interest resolution process and resolved. 
Dr. D. Hackbarth, Musculoskeletal Transplant Foundation, Board of Directors
Dr. J.C. Neilson, Musculoskeletal Transplant Foundation, Board of Trustees
Dr. S. Tutton, Benvenue, Consultant

All others in control of content had NO relevant financial relationships to disclose.
Drs. K. Baynes, M. Bedi, G. Carrera, R. Cerniglia, J. Charlson, M. Du Bois, S. Erickson, D. King, J. LoGiudice, A. MacKinnon, R. Mannem, J. Neilson, C. Johnstone, D. Johnstone, F. Johnston, P. Rossi, S. Suster, K. Turaga, S. Tutton, L. Hollingsworth-Burds PA-C, S. Veenendaal PA-C, J. Waugh APNP MSN, K. Horness PA-C.

CME Coordinator Contact Information

Name: 
Lori Hollingsworth-Burds PA-C
Phone number: 
+1 (414) 955-3226
Series date: 
Monday, January 1, 2018 - 7:45am to Thursday, January 31, 2019 - 8:45am
Series location: 
Froedtert Hospital
9200 W. Wisconsin Ave
Cancer Center
Milwaukee, WI 53226
United States

Sessions

Session Datesort descending
18031 MSK Tumor Board January 3, 2018 01/03/2018 - 7:45am to 8:45am
18031 MSK Tumor Board January 10, 2018 01/10/2018 - 7:45am to 8:45am
18031 MSK Tumor Board January 17, 2018 01/17/2018 - 7:45am to 8:45am
18031 MSK Tumor Board January 24, 2018 01/24/2018 - 7:45am to 8:45am
18031 MSK Tumor Board January 31, 2018 01/31/2018 - 7:45am to 8:45am
18031 MSK Tumor Board February 7, 2018 02/07/2018 - 7:45am to 8:45am
18031 MSK Tumor Board February 14, 2018 02/14/2018 - 7:45am to 8:45am
18031 MSK Tumor Board February 21, 2018 02/21/2018 - 7:45am to 8:45am
18031 MSK Tumor Board February 28, 2018 02/28/2018 - 7:45am to 8:45am
18031 MSK Tumor Board March 7, 2018 03/07/2018 - 7:45am to 8:45am

Pages